6-111580250-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147686.4(TRAF3IP2):​c.969C>A​(p.His323Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.806 in 1,614,006 control chromosomes in the GnomAD database, including 528,557 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. H323H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.85 ( 56204 hom., cov: 34)
Exomes 𝑓: 0.80 ( 472353 hom. )

Consequence

TRAF3IP2
NM_147686.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 0.260

Publications

43 publications found
Variant links:
Genes affected
TRAF3IP2 (HGNC:1343): (TRAF3 interacting protein 2) This gene encodes a protein involved in regulating responses to cytokines by members of the Rel/NF-kappaB transcription factor family. These factors play a central role in innate immunity in response to pathogens, inflammatory signals and stress. This gene product interacts with TRAF proteins (tumor necrosis factor receptor-associated factors) and either I-kappaB kinase or MAP kinase to activate either NF-kappaB or Jun kinase. Several alternative transcripts encoding different isoforms have been identified. Another transcript, which does not encode a protein and is transcribed in the opposite orientation, has been identified. Overexpression of this transcript has been shown to reduce expression of at least one of the protein encoding transcripts, suggesting it has a regulatory role in the expression of this gene. [provided by RefSeq, Aug 2009]
TRAF3IP2-AS1 (HGNC:40005): (TRAF3IP2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.539725E-7).
BP6
Variant 6-111580250-G-T is Benign according to our data. Variant chr6-111580250-G-T is described in ClinVar as Benign. ClinVar VariationId is 403565.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147686.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF3IP2
NM_147686.4
MANE Select
c.969C>Ap.His323Gln
missense
Exon 3 of 9NP_679211.2
TRAF3IP2
NM_147200.3
c.996C>Ap.His332Gln
missense
Exon 4 of 10NP_671733.2
TRAF3IP2
NM_001164281.3
c.969C>Ap.His323Gln
missense
Exon 3 of 9NP_001157753.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF3IP2
ENST00000368761.11
TSL:1 MANE Select
c.969C>Ap.His323Gln
missense
Exon 3 of 9ENSP00000357750.5
TRAF3IP2
ENST00000340026.10
TSL:1
c.996C>Ap.His332Gln
missense
Exon 4 of 10ENSP00000345984.6
TRAF3IP2
ENST00000528599.1
TSL:1
n.1164C>A
non_coding_transcript_exon
Exon 3 of 5

Frequencies

GnomAD3 genomes
AF:
0.855
AC:
130068
AN:
152180
Hom.:
56133
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.961
Gnomad AMI
AF:
0.860
Gnomad AMR
AF:
0.857
Gnomad ASJ
AF:
0.777
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.936
Gnomad FIN
AF:
0.854
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.778
Gnomad OTH
AF:
0.840
GnomAD2 exomes
AF:
0.852
AC:
213609
AN:
250782
AF XY:
0.849
show subpopulations
Gnomad AFR exome
AF:
0.966
Gnomad AMR exome
AF:
0.902
Gnomad ASJ exome
AF:
0.783
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.844
Gnomad NFE exome
AF:
0.783
Gnomad OTH exome
AF:
0.819
GnomAD4 exome
AF:
0.801
AC:
1171133
AN:
1461708
Hom.:
472353
Cov.:
66
AF XY:
0.805
AC XY:
585086
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.966
AC:
32347
AN:
33476
American (AMR)
AF:
0.899
AC:
40191
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.782
AC:
20448
AN:
26134
East Asian (EAS)
AF:
1.00
AC:
39686
AN:
39696
South Asian (SAS)
AF:
0.934
AC:
80542
AN:
86254
European-Finnish (FIN)
AF:
0.840
AC:
44857
AN:
53418
Middle Eastern (MID)
AF:
0.798
AC:
4599
AN:
5764
European-Non Finnish (NFE)
AF:
0.773
AC:
859550
AN:
1111884
Other (OTH)
AF:
0.810
AC:
48913
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
13132
26264
39397
52529
65661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20578
41156
61734
82312
102890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.855
AC:
130199
AN:
152298
Hom.:
56204
Cov.:
34
AF XY:
0.860
AC XY:
64056
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.961
AC:
39971
AN:
41576
American (AMR)
AF:
0.857
AC:
13114
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.777
AC:
2698
AN:
3472
East Asian (EAS)
AF:
0.998
AC:
5174
AN:
5182
South Asian (SAS)
AF:
0.936
AC:
4515
AN:
4824
European-Finnish (FIN)
AF:
0.854
AC:
9051
AN:
10604
Middle Eastern (MID)
AF:
0.765
AC:
225
AN:
294
European-Non Finnish (NFE)
AF:
0.778
AC:
52887
AN:
68016
Other (OTH)
AF:
0.842
AC:
1780
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
918
1836
2753
3671
4589
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
890
1780
2670
3560
4450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.803
Hom.:
190321
Bravo
AF:
0.858
ESP6500AA
AF:
0.959
AC:
4224
ESP6500EA
AF:
0.778
AC:
6695
ExAC
AF:
0.853
AC:
103599
Asia WGS
AF:
0.964
AC:
3352
AN:
3478
EpiCase
AF:
0.765
EpiControl
AF:
0.772

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 100% of patients studied by a panel of primary immunodeficiencies. Number of patients: 95. Only high quality variants are reported.

Candidiasis, familial, 8 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Other:1
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.057
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
9.6
DANN
Benign
0.82
DEOGEN2
Benign
0.027
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.098
N
LIST_S2
Benign
0.080
T
MetaRNN
Benign
5.5e-7
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-2.5
N
PhyloP100
0.26
PrimateAI
Benign
0.28
T
PROVEAN
Benign
0.65
N
REVEL
Benign
0.060
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.043
MutPred
0.17
Gain of relative solvent accessibility (P = 0.0999)
MPC
0.19
ClinPred
0.0024
T
GERP RS
3.5
Varity_R
0.036
gMVP
0.089
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1043730; hg19: chr6-111901453; COSMIC: COSV107416209; COSMIC: COSV107416209; API